Phase II study of weekly irinotecan and carboplatin for refractory or relapsed small-cell lung cancer. [electronic resource]
Producer: 20030221Description: 319-23 p. digitalISSN:- 0169-5002
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Camptothecin -- administration & dosage
- Carboplatin -- administration & dosage
- Carcinoma, Small Cell -- drug therapy
- Disease Progression
- Drug Administration Schedule
- Female
- Humans
- Infusions, Intravenous
- Irinotecan
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Neutropenia -- chemically induced
- Survival
- Thrombocytopenia -- chemically induced
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.